Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002241055 | SCV001379221 | uncertain significance | Ehlers-Danlos syndrome, classic type, 1 | 2019-09-19 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with COL5A1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamine with proline at codon 1809 of the COL5A1 protein (p.Gln1809Pro). The glutamine residue is highly conserved and there is a moderate physicochemical difference between glutamine and proline. |
MGZ Medical Genetics Center | RCV002241055 | SCV002580131 | uncertain significance | Ehlers-Danlos syndrome, classic type, 1 | 2022-05-20 | criteria provided, single submitter | clinical testing |